Dernières nouvelles pour Immutep (NASDAQ:IMMP) Stock

Immutep

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

Immutep Limited - American Depositary Shares

Immutep Ltd

Press Releases

Patient Enrolment Completed for EFTISARC-NEO Phase II Trial

Immutep Quarterly Activities Report Q2 FY25

Immutep to Present Pivotal TACTI-004 Trial in Progress Poster at the European Lung Cancer Congress 2025

First Patient Dosed in Immutep's TACTI-004 Phase III Trial in First Line Non-Small Cell Lung Cancer

Immutep to Participate in Upcoming Investor Conferences

Immutep Quarterly Activities Report Q3 FY25

Immutep's Efti in Combination with KEYTRUDA® (pembrolizumab) Drives Strong Overall Survival in Head and Neck Cancer with CPS <1

Immutep's Efti with KEYTRUDA® (pembrolizumab) & Chemotherapy Achieves High Response Rates in First-Line Non-Small Cell Lung Cancer

Immutep's Efti with Radiotherapy & KEYTRUDA® (pembrolizumab) Meets Primary Endpoint in Phase II for Soft Tissue Sarcoma

Immutep Announces Positive Update from Phase I Study of IMP761, a First-in-Class LAG-3 Agonist Antibody for Autoimmune Diseases

IMMP

Aldeyra Therapeutics, Inc. - Common Stock

Aldeyra Therapeutics

Allogene Therapeutics, Inc. - Common Stock

Allogene Therapeutics

Annexon

Candel Therapeutics

COMPASS Pathways Plc - American Depository Shares

Compass Pathways

Cardiff Oncology

DBV Technologies S.A. - American Depositary Shares

DBV Technologies

Design Therapeutics

Foghorn Therapeutics

I-MAB

Inhibrx Biosciences

Inozyme Pharma

Lineage Cell Therapeutics, Inc. Common Stock

Lineage Cell Therapeutics

Liminatus Pharma, Inc. - Class A Common Stock

Liminatus Pharma

Monopar Therapeutics

Nanobiotix

Neurogene

Palvella Therapeutics, Inc. - Common Stock

Palvella Therapeutics

Sagimet Biosciences Inc. - Series A Common Stock

Sagimet Biosciences

TriSalus Life Sciences, Inc. - Common Stock

TriSalus Life Sciences

Tonix Pharmaceuticals Holding Corp. - Common Stock

Tonix Pharmaceuticals

Entrada Therapeutics, Inc. - Common Stock

Comments

Immutep

Actualités

Dernières nouvelles pour Immutep (NASDAQ:IMMP) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL